Cogent Biosciences, Inc.
COGT
$11.40
-$0.02-0.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 245.66M | 287.08M | 335.52M | 363.22M | 435.74M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.22M | 9.40M | 6.01M | 6.76M | 6.16M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 252.88M | 296.47M | 341.53M | 369.97M | 441.90M |
|
|
|||||
| Total Current Assets | 252.88M | 296.47M | 341.53M | 369.97M | 441.90M |
| Net Property, Plant & Equipment | 26.05M | 26.56M | 27.60M | 28.41M | 29.35M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.86M | 4.86M | 4.86M | 4.86M | 4.86M |
| Total Assets | 283.80M | 327.90M | 384.02M | 429.94M | 476.11M |
|
|
|||||
| Total Accounts Payable | 14.15M | 12.01M | 15.06M | 8.98M | 15.57M |
| Total Accrued Expenses | 33.07M | 83.89M | 36.16M | 29.30M | 19.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.61M | 1.57M | 1.52M | 1.48M | 1.43M |
| Total Finance Division Other Current Liabilities | 484.00K | 373.00K | 306.00K | 252.00K | 636.00K |
| Total Other Current Liabilities | 484.00K | 373.00K | 306.00K | 252.00K | 636.00K |
| Total Current Liabilities | 49.32M | 55.71M | 53.05M | 40.00M | 36.69M |
|
|
|||||
| Total Current Liabilities | 49.32M | 55.71M | 53.05M | 40.00M | 36.69M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.48M | 15.90M | 16.31M | 16.71M | 17.09M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.00K | -- | -- | -- | -- |
| Total Liabilities | 64.80M | 71.61M | 69.36M | 56.71M | 53.78M |
|
|
|||||
| Common Stock & APIC | 1.04B | 1.00B | 994.72M | 980.22M | 862.19M |
| Retained Earnings | -931.47M | -859.48M | -791.56M | -720.92M | -661.97M |
| Treasury Stock & Other | 164.00K | 447.00K | 896.00K | -192.00K | -39.00K |
| Total Common Equity | 110.83M | 145.69M | 204.06M | 259.10M | 200.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 108.17M | 110.60M | 110.60M | 114.12M | 222.15M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 108.17M | 110.60M | 110.60M | 114.12M | 222.15M |
|
|
|||||
| Total Common Equity | 110.83M | 145.69M | 204.06M | 259.10M | 200.18M |
| Total Preferred Equity | 108.17M | 110.60M | 110.60M | 114.12M | 222.15M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 219.00M | 256.29M | 314.66M | 373.22M | 422.33M |
|
|
|||||